Sedation and Analgesia in the Mechanically Ventilated Patient

Learning objectives

• Use RASS to describe agitation, calm wakefulness, and sedation depth in a shared ICU language.
• Perform the assessment in the correct sequence: observe first, then voice, then physical stimulation.
• Target light sedation for most ventilated patients while recognizing when deeper sedation is intentional.

Chapter study guide

RASS Score Study Guide (Richmond Agitation–Sedation Scale)

What is RASS?

The RASS is a validated bedside tool used to assess a patient’s:

Level of alertness

Agitation

Sedation depth

It is most commonly used in:

ICU patients

Intubated/mechanically ventilated patients

Sedation monitoring during analgesia + sedative infusions

Key idea:

• RASS is the “language” your ICU team uses to communicate sedation goals.

Why do we use RASS?

Main purposes

Standardize sedation assessment (not vibes-based)

Prevent over-sedation (delirium, hypotension, prolonged ventilation)

Prevent under-sedation (self-extubation, dyssynchrony, distress)

Guide sedation targets and titration

The RASS Scale (from +4 to -5)

Agitation (positive numbers)

• +4 Combative

Violent, danger to staff, pulling lines, fighting hard

• +3 Very agitated

Aggressive behavior, pulls tube/lines, not redirectable

• +2 Agitated

Frequent non-purposeful movement, fights ventilator, anxious

• +1 Restless

Anxious, apprehensive, movement not aggressive

Neutral

• 0 Alert and calm

Awake, makes eye contact, calm

Sedation (negative numbers)

• -1 Drowsy

Not fully alert but awakens to voice

Eye contact >10 seconds

• -2 Light sedation

Briefly awakens to voice

Eye contact <10 seconds

• -3 Moderate sedation

Movement/eye opening to voice but no eye contact

• -4 Deep sedation

No response to voice

Movement only to physical stimulation

• -5 Unarousable

No response to voice or physical stimulation

How to Perform a RASS Assessment (Step-by-step)

This is important because RASS is not just “how sleepy do they look?”

Step 1: Observe (no stimulation)

If patient is:

Alert & calm RASS 0

Agitated/restless score +1 to +4(you don’t need to stimulate them)

Step 2: If not alert use voice

Say:

“[Name], open your eyes.” (or “Look at me.”)

Then score:

Eye contact >10 sec -1

Eye contact <10 sec -2

Movement/eye opening but no eye contact -3

Step 3: If no response to voice physical stimulation

Try shoulder shake or sternal rub (appropriately).

Then score:

Movement to stimulation -4

No movement -5

The trick:

• RASS depends on the best response to stimulation.

Typical Sedation Targets

Most ICU patients should be targeted to:

• RASS -1 to 0 (light sedation)

Because this supports:

earlier weaning/extubation

less delirium

earlier mobilization

fewer sedation complications

When do we intentionally aim deeper? (RASS -3 to -5)

You may need deep sedation when:

Severe ARDS (proning, high vent settings)

Refractory ventilator dyssynchrony

Neuromuscular blockade (paralysis)

Status epilepticus

Elevated ICP / severe TBI

Teaching pearl:

Deep sedation should be a “reasoned choice,” not the default.

How RASS fits into “analgesia-first” sedation

Agitation isn’t always anxiety.

Before increasing sedatives, always ask:

Is the patient in pain?

Are they air hungry?

Are they hypoxic, acidotic, febrile, withdrawing?

• RASS tells you where they are, but not why.

Learning objectives

• Use CPOT to evaluate pain in nonverbal or mechanically ventilated patients.
• Differentiate analgesia needs from sedation needs.
• Trend CPOT before, during, and after painful stimuli or analgesic interventions.

Chapter study guide

CPOT (Critical-Care Pain Observation Tool)

What is CPOT?

• CPOT is a validated bedside tool used to assess pain in:

Intubated patients

Nonverbal patients

Critically ill ICU/ED patients who can’t self-report pain

Key concept:

Sedation ≠ analgesia.

A patient can be “calm” and still be in pain

Why do we use CPOT?

Because intubated patients often can’t tell you they hurt, and pain shows up as:

Tachycardia / hypertension

• Ventilator dyssynchrony

Grimacing

Guarding / rigidity

Agitation that looks like “anxiety”

• CPOT helps you:

Detect pain earlier

Titrate analgesia logically

Avoid reflexively escalating sedation

What does CPOT measure?

• CPOT scores behavioral signs of pain in 4 domains:

1) Facial expression

2) Body movements

3) Muscle tension

4) Ventilator compliance (or vocalization if not intubated)

Each category is scored 0–2, total score 0–8

• CPOT Scoring System (0–8)

1) Facial Expression

• 0: Relaxed / neutral
• 1: Tense (frown, brow lowering, orbit tightening)
• 2: Grimacing (pronounced facial tension, clenched jaw)

2) Body Movements

• 0: No movement / normal position
• 1: Protective movements (slow, cautious, touching painful area)
• 2: Restless / pulling tubes / thrashing

3) Muscle Tension (assess by passive flex/extension)

• 0: Relaxed
• 1: Tense / resistant
• 2: Very tense / rigid

This is a big CPOT pearl:

You actually check tone — it’s not just “looks stiff.”

4) Ventilator Compliance (or Vocalization if extubated)

If intubated:

• 0: Tolerating ventilator / no alarms
• 1: Coughing but tolerating / occasional dyssynchrony
• 2: Fighting ventilator / frequent dyssynchrony / alarms

If extubated:

• 0: Talking normally or no sound
• 1: Sighing / moaning
• 2: Crying out / sobbing

How to Perform CPOT (Step-by-step)

This makes your CPOT score more accurate and reproducible

Step 1: Observe at baseline

Score CPOT while patient is resting.

Step 2: Observe during a painful procedure

Examples:

suctioning

turning/repositioning

line placement

wound care

chest tube manipulation

Pain often shows up during stimulation, even if baseline looks okay.

Step 3: Reassess after analgesia

• CPOT should improve after pain control.
• CPOT is best used as a trend tool:

Before during after interventions

What do CPOT numbers mean?

While exact thresholds vary by institutional protocols, clinically:

• CPOT 0–2: minimal/acceptable pain
• CPOT ≥3: likely pain consider analgesia escalation

Where CPOT fits in the ICU workflow

Think:

Pain = CPOT

Sedation = RASS

Delirium = CAM-ICU

A super clean way to teach it is:

Treat pain first (CPOT)

then target sedation (RASS)

then screen delirium (CAM-ICU)

• Clinical Interpretation: “Agitation ≠ anxiety”

If the patient is moving, fighting the vent, or tachycardic…

Before you increase sedation, ask:

Is CPOT high?

Do they have a painful stimulus? (fracture, burns, chest tube)

Are they air hungry? (vent settings/flow starvation)

Teaching pearl:

A high CPOT with a high RASS = pain is driving agitation more often than people think

Learning objectives

• Recognize delirium as acute brain dysfunction in critical illness.
• Apply the four CAM-ICU features in the correct logic pattern.
• Know when deep sedation prevents delirium assessment.

Chapter study guide

CAM-ICU (Confusion Assessment Method for the ICU)

What is CAM-ICU?

• CAM-ICU is a validated bedside tool used to screen for delirium in:

ICU patients

Intubated / mechanically ventilated patients

Nonverbal patients

Key idea:

Delirium is acute brain dysfunction — and it’s common in critical illness.

Why do we care about delirium?

Delirium is associated with:

Longer ICU stay

Longer time on the ventilator

Higher mortality risk

Long-term cognitive impairment (“ICU brain”)

Increased distress for patients + families

• CAM-ICU helps you detect delirium reliably instead of guessing.

Foundational concept: what is delirium?

Delirium = acute onset + fluctuating mental status with:

Inattention

Disorganized thinking

Altered level of consciousness

Delirium can be:

Hyperactive

Agitated, pulling lines, restless

Hypoactive (commonly missed!)

Quiet, withdrawn, “sleepy,” not engaging

When can you use CAM-ICU?

You generally need the patient to be at least somewhat arousable.

Rule of thumb:

If RASS ≥ -3, you can attempt CAM-ICU

If RASS -4 or -5, patient is too deeply sedated to assess delirium

So your workflow often is:

• RASS first then CAM-ICU

CAM-ICU = 4 Features

• CAM-ICU tests 4 features:

Feature 1: Acute onset OR fluctuating course

Is there a new mental status change from baseline?

Does it come and go / fluctuate over the day?

Examples:

Normal this morning confused tonight

Alternating agitation and somnolence

Feature 2: Inattention

This is the core of delirium.

You test attention using:

“Letters” attention test (classic)

Say a sequence like:

S A V E A H A A R T

Ask patient to squeeze your hand (or blink) when they hear A

Errors = inattention:

Misses the A’s

Squeezes on wrong letters

Stops participating

If they can’t pay attention, delirium becomes much more likely.

Feature 3: Altered level of consciousness

Anything other than “alert/calm” counts.

If RASS ≠ 0, then Feature 3 is present

(Examples: RASS +2, -2, etc.)

Feature 4: Disorganized thinking

Ask simple questions or commands.

Common examples:

“Will a stone float on water?”

“Are there fish in the sea?”

“Does one pound weigh more than two pounds?”

“Hold up this many fingers”

“Now do the same with the other hand”

Wrong answers or inability to follow = disorganized thinking

How to Interpret CAM-ICU

• CAM-ICU is POSITIVE for delirium if:

Feature 1 AND Feature 2 AND (Feature 3 OR Feature 4)

• CAM-ICU (+) = 1 + 2 + (3 or 4)

Step-by-Step CAM-ICU Approach (practical workflow)

Step 0: Check RASS

If RASS -4/-5 too sedated (unable to assess)

If RASS ≥ -3 proceed

Step 1: Feature 1 (acute/fluctuating)

Look at chart + nursing report.

Step 2: Feature 2 (attention)

Do the letters test.

Step 3: Feature 3 (LOC)

Use RASS (anything not 0 counts).

Step 4: Feature 4 (thinking)

Simple questions/commands.

Quick Whiteboard Memory Tools

• CAM-ICU logic:
• 1 + 2 + (3 or 4)
• 4 features summary:

Acute/fluctuating

Inattention

Altered consciousness (RASS ≠ 0)

Disorganized thinking

Learning objectives

• Use propofol as a rapid, titratable sedative-hypnotic while recognizing that it is not an analgesic.
• Monitor for hypotension, hypertriglyceridemia, and propofol-related infusion syndrome.
• Titrate propofol to a defined sedation target rather than to immobility.

Chapter study guide

Propofol in the Mechanically Ventilated Patient

What propofol is (and what it is not)

Propofol is a sedative-hypnotic used for rapid, titratable sedation in mechanically ventilated adults.

Great for quick on / quick off sedation

Helps with ventilator synchrony

Not an analgesic (it does not treat pain) pair with analgesia when needed

Mechanism of action (high yield)

Propofol primarily:

Potentiates GABA-A receptor activity inhibitory neurotransmission hypnosis/sedation It also has other CNS effects (less clinically testable), but the key mechanism is GABA-A.

Clinical goals for propofol sedation

• Most ventilated patients: target light sedation
• RASS -1 to 0 (unless clear indication for deeper sedation)

Common reasons to go deeper (temporarily) :

Severe ARDS / proning

Refractory ventilator dyssynchrony

Status epilepticus

ICP crisis

Neuromuscular blockade (paralysis) (requires deep sedation + analgesia)

Dosing & titration (conceptual - NOT medical advice)

Typical infusion dosing (adult ICU sedation)

• Start: ~5–10 mcg/kg/min
• Titrate: increase/decrease in 5–10 mcg/kg/min steps every 5–10 minutes until target sedation achieved
• Common maintenance range: roughly 5–50 mcg/kg/min (varies by patient and goal)

Package labeling includes maintenance dosing ranges for sedation in monitored settings (e.g., commonly cited 25–100 mcg/kg/min depending on context and patient response).

Boluses?

Bolus dosing can rapidly deepen sedation but increases risk of hypotension/apnea.

Reassessment

Check RASS frequently during titration (q5–15 min initially)

• After stable: reassess on a schedule + with any clinical change

Teaching pearl:

Titrate to a target RASS, not to “no movement.”

What to monitor while on propofol

Always:

• BP/MAP, HR (watch for hypotension/bradycardia)
• Depth of sedation (RASS)

Monitoring (especially prolonged/high dose):

Triglycerides (risk of hypertriglyceridemia)

Consider pancreatitis risk if TG significantly elevated / symptoms / lipase concern (association debated but clinically relevant)

Acid–base status, lactate, CK, renal function if concern for PRIS

Adverse effects (the “must know” list)

1) Hypotension (very common)

Due to vasodilation + some myocardial depression

• Worse in: hypovolemia, sepsis/shock, RV failure, elderly

2) Bradycardia

Less common than hypotension but clinically important

3) Hypertriglyceridemia

Propofol is delivered in a lipid emulsion; TG elevations are not rare in ICU use

4) Pancreatitis (relationship not perfectly clear)

TG elevation is a pancreatitis risk factor; studies evaluate the association and clinical impact

5) Propofol-Related Infusion Syndrome (PRIS) (rare, high stakes)

A potentially fatal syndrome characterized by combinations of:

Metabolic acidosis

Rhabdomyolysis / CK

Hyperkalemia

Acute kidney injury

Arrhythmias / cardiovascular collapse

Elevated lactate

Risk increases with higher doses and longer duration; reviews commonly cite avoiding very high infusion rates and prolonged infusions when possible.

“Unexplained acidosis + rising CK + shock/arrhythmia on high-dose propofol = PRIS until proven otherwise.”

6) Other

Injection site pain (less relevant for ICU infusions)

Green urine (benign, rare)

Increased caloric load from lipid emulsion (nutrition implications)

Contraindications & “relative no’s”

Hard contraindications (per labeling)

Known hypersensitivity to propofol/components

History of anaphylaxis to eggs/egg products or soy/soy products (listed in U.S. labeling)

Important nuance (clinically relevant)

Some allergy organizations and studies argue most egg/soy food allergies don’t necessarily translate to propofol reactions, and many patients can receive propofol safely—but labeling still lists these contraindications, so local policy and severity (especially true anaphylaxis history) matter.

Relative cautions

Profound shock/hemodynamic instability (propofol may worsen hypotension)

Situations requiring prolonged deep sedation at high doses ( PRIS risk)

Concern for severe hypertriglyceridemia/pancreatitis

What does the research/guidelines say?

Guideline positioning

• 2018 SCCM PADIS: suggests propofol or dexmedetomidine over benzodiazepines for sedation in mechanically ventilated adults (conditional, low-quality evidence).
• 2025 PADIS focused update: suggests dexmedetomidine over propofol when light sedation and/or delirium reduction are the highest priorities (conditional, moderate evidence).

Head-to-head outcomes (propofol vs dexmedetomidine)

A large randomized trial found no significant difference between dexmedetomidine and propofol in days alive without delirium or coma (i.e., broadly similar on that primary outcome).

Practical take:

Propofol remains a core first-line sedative because it’s fast and titratable—just be intentional about dose, duration, hemodynamics, and monitoring.

“Rough approach” on the vent

Set your target (often RASS -1 to 0)

Treat pain first (opioid/analgesia as needed)

Start propofol 5–10 mcg/kg/min, titrate q5–10 min

If BP drops:

reassess volume status/pressor needs

reduce propofol dose

consider switching strategy (e.g., dexmedetomidine)

Monitor TG, watch for PRIS signs

Learning objectives

• Recognize ketamine as an NMDA antagonist with analgesic, dissociative, and opioid-sparing properties.
• Choose ketamine thoughtfully when hemodynamics, bronchospasm, pain, or opioid tolerance make it useful.
• Monitor for sympathetic effects, hypersalivation, psychomimetic effects, and paradoxical hypotension in catecholamine-depleted shock.

Chapter study guide

Ketamine in the Mechanically Ventilated Patient

What ketamine is (and what it isn’t)

Ketamine is a dissociative anesthetic that can be used in ventilated patients as:

Adjunct analgesia (opioid-sparing)

Adjunct sedation (especially when hypotension limits other agents)

A useful option in bronchospasm/asthma, opioid tolerance, and hemodynamically tenuous patients (with caveats)

Key point: ketamine can provide analgesia and sedation, but it’s often best thought of as an adjunct “bridge” or “booster” agent, not the only sedative for every patient.

Mechanism of action (high yield)

The headline mechanism:

Noncompetitive NMDA receptor antagonism analgesia + dissociation + anti-hyperalgesia effects.

Additional clinically relevant actions:

Some activity at opioid receptors and other CNS pathways (contributes to analgesia/sedation).

Sympathomimetic effects (often HR/BP) via catecholamine release/reuptake effects—BUT in catecholamine-depleted shock, BP can still fall.

Ketamine = NMDA antagonist analgesia + dissociation; often supports BP/bronchodilation.

When ketamine is especially useful on the vent

Situations where ketamine often “makes sense” clinically:

Opioid-tolerant or hard-to-control pain patients (trauma, burns, chronic opioid use)

Hemodynamic fragility where propofol escalation would tank BP

Severe bronchospasm (asthma) needing sedation + bronchodilation vibes

When you want opioid-sparing analgesia (reduce total opioid burden)

Dosing & titration (practical ICU-style)

Conceptual, not medical advice

Ketamine dosing on the vent varies a lot across studies and hospitals. A 2023 review of continuous infusion ketamine for ICU sedation found wide ranges, with many studies using <1 mg/kg/hr, often <0.5 mg/kg/hr.

1) “Pain-dose” ketamine (analgesic adjunct)

A common clinical starting point:

0.1–0.3 mg/kg/hr as a basal analgesic infusion Titrate slowly based on pain scores (e.g., CPOT) and opioid needs.

2) “Sedation-dose” ketamine (adjunct sedative)

Commonly used ranges in ICU literature/practice:

Roughly 0.5–1 mg/kg/hr (sometimes higher depending on goals/patient) Observational ICU data show some patients receiving ~1–2 mg/kg/hr, with occasional higher rates reported (center-dependent).

Bolus dosing?

Boluses can rapidly deepen dissociation but increase risks of:

hypertension/tachycardia

psychomimetic effects

overshoot sedation

If you do bolus in the critically ill, do it deliberately and reassess fast.

Titration concept (simple + safe)

• Set targets: Pain (CPOT) + Sedation (RASS)

Start low, especially if older, delirium-prone, or CAD/aortic pathology risk

Up-titrate in small steps q15–30 min until effect

Reassess frequently and trend scores (don’t “set and forget”)

Monitoring

• RASS (depth of sedation)

CPOT/BPS (pain)

HR/BP (sympathomimetic or paradoxical hypotension in catecholamine-depleted states)

Secretions (hypersalivation)

Delirium screen (CAM-ICU)

Pearl: ketamine can look like agitation (nystagmus, dissociation, odd movements). Make sure you’re interpreting behavior through the right lens.

Adverse effects (must know)

1) Cardiovascular stimulation (common)

Hypertension + tachycardia are classic.

In catecholamine-depleted shock, ketamine’s direct myocardial depressant effects can “show,” and BP may drop (less common but important).

2) Psychomimetic effects

Dysphoria, hallucinations, emergence reactions (more prominent as patients wake/lighten)Often blunted when co-administered with another sedative (propofol/dex).

3) Hypersalivation

Can worsen secretion burden and suctioning needs.

4) Increased intracranial/intraocular pressure concerns (nuanced)

Traditional teaching worried about ICP; modern data are more mixed and ketamine is often used safely in neuro patients when clinically indicated—but many references still list caution in elevated ICP scenarios and practice varies. (If your channel covers neuro, this is a great “myth vs nuance” sidebar.)

5) Other toxicity themes (context-dependent)

Nausea/vomiting (less relevant while intubated)

Rare severe reactions

Contraindications & major cautions

Absolute contraindications are mostly “hypersensitivity,” but clinically we think in risk buckets.

Use extreme caution / consider alternatives if:

Severe or uncontrolled hypertension, recent major CV events, severe cardiovascular disease (since BP/HR can rise)

Aortic dissection or situations where sympathetic surge is dangerous (conceptually tied to the above)

Active psychosis or severe psychiatric instability (risk of psychomimetic effects)

Markedly elevated ICP where your team/protocol avoids it (institution-dependent)

Practical balancing line:

Ketamine is hemodynamically “friendly”… until it isn’t (CAD/HTN/aortic pathology, or catecholamine-depleted shock).

What does the research say?

1) Adjunct ketamine may reduce sedative requirements (signal)

A 2021 pilot RCT (adjunct ketamine vs standard care) focused on feasibility and explored sedative needs; it reflects ongoing interest in ketamine as an adjunct analgosedative.

2) Delirium and opioid-sparing outcomes are mixed

A randomized double-blind trial reported low-dose ketamine reduced delirium but did not reduce opioid consumption (as titled/reported).

Overall, outcomes across studies vary—protocols, co-sedatives, and patient selection matter.

3) Dosing in practice is variable, generally modest

A 2023 review found most ICU ketamine infusion studies used <1 mg/kg/hr (many <0.5 mg/kg/hr), but ranges across literature are wide.

Teaching takeaway:

Ketamine has promising adjunct benefits (opioid/sedative sparing, unique physiology), but it’s not a universal “better sedation” solution—use it for the right patient and goal.

Learning objectives

• Use dexmedetomidine for light, cooperative sedation when appropriate.
• Recognize bradycardia and hypotension as key adverse effects.
• Avoid relying on dexmedetomidine alone when deep sedation is required.

Chapter study guide

Dexmedetomidine in the Mechanically Ventilated Patient

What dexmedetomidine is (and what it isn’t)

Dexmedetomidine (often “dex”) is an IV sedative that creates a more arousable / cooperative sedation state.

Helps with anxiety, agitation, and ventilator tolerance

Usually causes minimal respiratory depression (handy when we’re trying to lighten sedation and assess readiness)

Not a primary analgesic (but does have some pain control)

Not ideal as the only agent when deep sedation is required (e.g., severe ARDS + paralysis)

Mechanism of action (high yield)

Dexmedetomidine is a selective α2-adrenergic agonist.

What that does clinically:

sympathetic outflow (“sympatholysis”) calmer, lower catecholamine tone

Sedation that resembles a sleep-like state (patients can often awaken and follow commands)

Dex = α2 agonist sympatholysis + arousable sedation.

When dex is especially useful on the vent

Dex shines when your sedation goal is light and you want:

better participation in neuro exam

less “snowed” patient while still calm

help transitioning to SBT/extubation readiness

agitation that’s blocking weaning/extubation (classic use case)

This aligns with ICU guideline positioning (see evidence section).

Dosing, titration, and a practical bedside strategy

Not medical advice; conceptual only

Typical ICU infusion dosing (adult)

From FDA labeling:

• Maintenance infusion: 0.2–0.7 mcg/kg/hr, adjusted to desired sedation level

Label also describes initiating around 0.6 mcg/kg/hr and titrating, with doses up to 1 mcg/kg/hr in ICU sedation

Loading dose? (often skipped in ICU)

Label includes a loading dose (1 mcg/kg over 10 min) in some contexts

In real-world ICU/ED practice, many clinicians avoid the loading dose because it can trigger bradycardia/hypotension. (This is a practical pearl; policies vary.)

Titration approach (simple + safe)

Start 0.2–0.3 mcg/kg/hr

Titrate by 0.1–0.2 mcg/kg/hr every ~15–30 minutes to reach a target (often RASS -1 to 0)

If you need deep sedation quickly, dex is usually not the best hammer—consider propofol, plus analgesia, etc.

Dose reductions to consider

Label recommends considering dose reduction in:

Age >65

Hepatic impairment

What to monitor

Because dex is sympatholytic, the big watch-outs are:

HR (bradycardia)

• BP/MAP (hypotension; sometimes hypertension early/with loading)

Sedation target (RASS)

Practical monitoring pearl:

If the patient’s MAP is marginal and HR is already low, dex can be the agent that tips them over.

Adverse effects (the “must know” list)

1) Bradycardia

Most characteristic adverse effect

Higher risk with:

baseline bradycardia

conduction disease/heart block

high vagal tone

coadministration of other AV nodal blockers

loading dose

2) Hypotension

From decreased sympathetic tone (and sometimes relative hypovolemia becomes “unmasked”)

3) Hypertension (less common; classically with loading)

Peripheral α2 effects can cause transient HTN, especially with rapid load

4) Withdrawal / rebound (after prolonged use)

Abrupt discontinuation after long infusions may contribute to agitation, tachycardia, or hypertension in some patients (clinically recognized; practice varies around weaning).

Contraindications & major cautions

Rather than “absolute contraindications,” think high-risk situations where dex can be a bad match:

Use extreme caution or avoid if:

significant bradycardia or high-grade AV block (without pacing)

profound hemodynamic instability (shock with low HR/MAP)

severe vent-dependent deep sedation needs (dex may not achieve goals alone)

Label also emphasizes dose reductions in older adults and hepatic impairment.

What does the research/guidelines say?

Guidelines

• 2018 SCCM PADIS: suggests using propofol or dexmedetomidine over benzodiazepines for sedation in mechanically ventilated adults.
• 2025 SCCM PADIS Focused Update: suggests dexmedetomidine over propofol when light sedation and/or delirium reduction are the highest priorities (conditional recommendation, moderate quality evidence).

Head-to-head trial vs propofol (key RCT)

A major randomized trial (often discussed as MENDS2) found no meaningful difference between dexmedetomidine and propofol in days alive without delirium or coma, ventilator-free days, or 90-day mortality.

Practical take:

Dex is excellent for maintaining light, interactive sedation and facilitating weaning.

It’s not necessarily “better” than propofol for hard outcomes in all-comers—but guideline panels still lean toward dex in situations where light sedation/delirium priorities dominate.

Rough approach

Set sedation goal (often RASS -1 to 0)

Treat pain first (opioid/other analgesia as needed)

Choose dex if:

you want arousable sedation

you’re moving toward SBT/extubation

delirium risk is high

Start dex 0.2–0.3 mcg/kg/hr, titrate slowly

If bradycardia/hypotension develops:

decrease/stop dex

correct volume issues

consider switching agents

Learning objectives

• Use fentanyl as a potent IV opioid analgesic for ventilated patients while recognizing it is not a primary sedative-hypnotic.
• Monitor respiratory, hemodynamic, gastrointestinal, delirium, tolerance, and withdrawal consequences.
• Recognize opioid-induced chest wall rigidity after rapid or high-dose fentanyl exposure.

Chapter study guide

Fentanyl in the Mechanically Ventilated Patient

What fentanyl is (and what it isn’t)

Fentanyl is a potent opioid analgesic commonly used in intubated patients to treat:

pain from illness/injury/procedures

distress from the endotracheal tube and suctioning

“air hunger” discomfort (to a degree)

• Key point: fentanyl provides analgesia first and may provide some sedation, but it is not a primary sedative-hypnotic(like propofol).
• Critical care mantra: Analgesia-first (treat pain before escalating sedatives).

Mechanism of action (high yield)

Fentanyl is a µ-opioid receptor agonist:

neurotransmitter release in pain pathways

pain tolerance + pain perception

also contributes to respiratory drive suppression and sympathetic blunting

When fentanyl is especially useful on the vent

Fentanyl is a great choice when you need:

rapid-onset IV analgesia

easy titration for ongoing painful stimuli (ETT, chest tubes, trauma, burns)

analgesia as the “base layer” while you titrate sedation separately

Guidelines and ICU liberation resources emphasize opioids as first-line pharmacologic therapy for ICU pain (using the lowest effective dose and protocols when possible).

Dosing & titration (conceptual - not medical advice)

Common continuous infusion range (analgesia)

A commonly referenced ICU range is:

0.5–5 mcg/kg/hr (titrate to pain scores/comfort)

Clinical practice varies by unit and patient (opioid tolerance, shock physiology, deep sedation needs, etc.). Use your local protocol.

Titration strategy (foundational approach)

Pick a pain target (e.g., CPOT goal)

Start low (especially in shock/elderly)

Titrate in small steps (e.g., adjust infusion and/or add boluses for procedures)

Reassess frequently and trend your scores

Good “score bundle” workflow:

• Pain: CPOT
• Sedation: RASS
• Delirium: CAM-ICU

Bolus cautions

Rapid IV boluses can be useful (e.g., suctioning/turning), but large/fast boluses increase risk of:

apnea/respiratory depression (still relevant even on the vent)

chest wall rigidity (“wooden chest syndrome”)

Monitoring

Clinical targets

pain score trends (CPOT/BPS)

vent synchrony / distress

total opioid exposure (avoid drift into deep sedation by “analgesia creep”)

Safety monitoring

RR/vent mechanics, ETCO₂/ABGs as appropriate (opioid effect can worsen hypercapnia)

BP/HR (opioids can contribute to hypotension/bradycardia in susceptible patients)

bowel function (ileus/constipation)

signs of tolerance/withdrawal with prolonged infusions

Adverse effects

1) Respiratory depression / apnea

Even in ventilated patients this matters (CO₂ retention, delayed weaning, need for higher vent support). Labeling warns about serious respiratory depression and profound sedation, especially with other CNS depressants.

2) Hypotension and bradycardia

More likely with:

hypovolemia, shock

coadministration with sedatives/vasodilators

high doses

3) Ileus / constipation / urinary retention

Classic opioid physiology.

4) Delirium contribution

Opioids can contribute (especially at higher doses), though delirium is multifactorial; minimizing total sedative burden is key.

5) Chest wall rigidity (“wooden chest syndrome”) (rare but high-stakes)

Presentation can include:

sudden difficulty ventilating

rising peak pressures / poor compliance

hypercapnia and desaturation

Risk increases with rapid injection, large doses, and sometimes prolonged exposure; treatment often includes airway/vent support, naloxone, and/or neuromuscular blockade depending on severity.

“Sudden ventilator difficulty after fentanyl bolus consider wooden chest.”

Contraindications & major cautions

Hard contraindication (general)

Known hypersensitivity to fentanyl or formulation components. (Included in prescribing information/labeling.)

Caution

hemodynamic instability (hypotension risk)

concomitant CNS depressants (additive sedation/respiratory effects)

prolonged infusions: tolerance, withdrawal, and opioid-induced hyperalgesia considerations

Evidence & what research suggests

Guidelines / best-practice framing

The Society of Critical Care Medicine PADIS guideline materials emphasize opioid-based strategies for ICU pain (lowest effective dose, protocols) and structured monitoring rather than “set and forget.”

Rough bedside approach

• Set goals: pain target (CPOT), sedation target (RASS)
• Start analgesia: fentanyl infusion (± bolus for procedures)

Titrate to pain, not to “no movement”

If agitation persists, reassess causes:

pain vs dyspnea/vent settings vs delirium vs metabolic issues

Add/adjust sedative (propofol/dex) only as needed

Daily rethink: can you lighten? can you transition to enteral? prevent withdrawal?